RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Bad news on red meat: Eating more is linked to diabetes risk

    Bad news on red meat: Eating more is linked to diabetes risk
    Nutritionists known for issuing warnings about the health risks of eating red meat reiterated their message this week, confirming a link between red meat consumption and Type 2 diabetes -- and showing, in a new follow-up study, that the association...
  • Athletes only too happy to be 'lab rats'

    Athletes only too happy to be 'lab rats'
    After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound. But the failed experimental drug, called GW501516, is making a comeback in another...
  • Animal studies riddled with bias, report finds

    Animal studies riddled with bias, report finds
    Too much good news in medicine may be bad news for science, according to a new study that suggests animal research is riddled with bias that allows too many treatments to advance to human trials. Researchers examined data from thousands of experiments...
  • FDA approves skin cancer drugs and genetic test

    FDA approves skin cancer drugs and genetic test
    The Food and Drug Administration on Wednesday announced its approval of two new drugs and a diagnostic test that can be used to treat advanced or inoperable melanoma, the most dangerous form of skin disease. Advanced melanoma has joined a wide range...
  • Deals of the day -- mergers and acquisitions

    July 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** Dell Inc founder Michael Dell raised his $24.4 billion bid by less than 1 percent just hours before it was to be put to a vote,...
  • Things to know for Monday

    Things to know for Monday
    More than a dozen firefighters in Arizona died this weekend, political demonstrations in Brazil were suppressed by more than 10,000 troops, and Egypt is seeing resurgent political demonstrations of its own. Welcome to your post-weekend trends report for...
  • Glaxo anti-cancer cocktail gets regulatory approval

    Glaxo anti-cancer cocktail gets regulatory approval
    After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...
  • Pointing to threat, pulling in profit

    Pointing to threat, pulling in profit
    WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...
  • Human Genome to lay off 97 workers

    Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
  • State AG sues maker of diabetes drugs for false advertising

    State AG sues maker of diabetes drugs for false advertising
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
  • Human Genome Sciences announces plan to lay off 114

    Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...